EMCDDA Home
  • EN
Search

Tips: Click on a column heading to order the results.Use the filters to limit the number of results.

More help>>

Displaying results 1–10 of 29 where Substances addressed by the intervention is Opiates

<< previous next >>

Filter results:

Project description Intervention type Evaluation type Setting Target group Country Quality level
Title: Effects Of Medical Heroin Co-prescription For Treatment-refractory Chronic Addicts
Summary: This study looks at the positive and negative effects of a one year heroin prescription to treatment refractory chronic opiate addicts initially participating unsuccessfully in a methadone programme. This study shows that medical heroin prescription appears to be feasible and safe for treatment refractory chronic opiate addicts. >>
treatment outcome evaluation, impact evaluation, process evaluation adults Netherlands 2
Title: Inpatient Cue Exposure Therapy To Prevent Relapse Of Drug Abuse
Summary: The purpose of this study is to investigate if relapse rates of opiate addicts are reduced more substantially by cue exposure therapy compared to emotional coping skills training. The study takes place in a therapeutic community and results will be available during 2004. >>
treatment outcome evaluation adults Netherlands 2
Title: Relapse Prevention (CRA) With Naltrexone Maintenance For Opiate Addicts
Summary: The purpose of this study was to explore the effects of naltrexone maintenance combined with psychosocial treatment; namely CRA, the Community reinforcement Approach. >>
treatment outcome evaluation adults Netherlands 1
Title: Programme to improve access to treatment for opiate users in Castile and Leon
Summary: Based in Castile and Leon, the main objectives of the regional methadone maintenance treatment programme is to improve rural access to the service and to reduce waiting lists. The principle is to bring the services administering methadone as close as possible to users and improve and reinforce care facilities handling large numbers of cases. >>
treatment process evaluation general population, adults Spain 1
Title: Assessment of factors that influence the introduction of Hepatitis C treatment for Drug Users
Summary: During pilot studies that tested PegInterferon treatment for Hepatitis C on places where methadone was distributed, patient compliance was (unexpectedly) very high. This process evaluation of the National Hepatitis Center determines the feasibility of a general treatment programme for drug users. >>
treatment process evaluation adults Netherlands 1
Title: Total Quality Management for the Dependencies Treatment System (TQM 1/2000)
Summary: A description of the implementation of a quality management system which enables the measurement and evaluation of the performance and outcome of therapeutic communities. >>
impact evaluation, process evaluation adults Italy 1
Title: Immediate Detoxification Of Opiates With Naltrexone Under Anaesthetics
Summary: This study contextualises and compares the effectiveness of two methods of rapid detoxification, naltrexone with anaesthesia and naltrexone without anaesthesia. There appear to be no short term differences in effectiveness of rapid detoxification with naltrexone under anaesthesia and without anaesthesia. Furthermore, detoxification under anaesthesia is a less safer method and more expensive. >>
treatment outcome evaluation, impact evaluation, process evaluation adults Netherlands 2
Title: Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial
Summary: The intervention aimed to significantly reduce the use of street heroin amongst individuals who were chronically addicted to heroin and who had not previously responded to conventional treatment. Suitable patients were enrolled and were randomly allocated to 26 weeks of treatment with supervised injectable heroin, supervised injectable methadone or optimised oral methadone within an open-label randomised controlled trial. The intervention took place in supervised injecting clinics in three locations in England. Weekly urinalysis was used to monitor whether participants were continuing to use street heroin in addition to their prescribed treatment. The trial showed that significantly more of those participants who were treated with injectable heroin, compared to those on oral methadone, had achieved weekly urine samples showing no use of street heroin during 50% or more of the weeks 14 to 26 of treatment. There was no significant difference between those on injectable methadone treatment and those on oral methadone. The authors of the study recommended that injectable medicinal heroin should be more widely available under supervision to chronic heroin addicts who were not benefiting from conventional treatments. >>
treatment outcome evaluation outpatient adults England 3
Title: Take Home Naloxone (THN)
Summary: The Take Home Naloxone (THN) project provides training to opiate users and their carers on the administration of naloxone and first-aid in an overdose event. THN kits are issued to opiate users on completion of the training. >>
harm reduction outcome evaluation, process evaluation low threshold service, needle/syringe provision, outreach/drug scene United Kingdom 2
Title: National Take-Home Naloxone (THN) Programme Scotland
Summary: In the decade 2002-2012 the number of drug-related deaths (DRDs) registered in Scotland increased and the rate of DRDs is higher than those seen in other parts of the UK. The majority of these deaths are due to fatal accidental opioid ovedoses. Naloxone is a “competitive opioid antagonist”, which can temporarily relieve dangerous symptoms caused by high levels of opioids in the blood by temporarily removing them from receptors in the brain. In the event of an overdose this provides valuable extra time for emergency services to arrive and deliver treatment. The aim of the National Take Home Naloxone (THN) Programme is to contribute to a reduction in DRDs in Scotland through the provision of THN kits and specialist training to opioid users, their friends, family, carers, partners and other people they associate with and who are likely to be in the vicinity if an overdose occurs. Kits are distributed in community health settings and in prisons at the point of liberation. >>
harm reduction outcome evaluation, impact evaluation low threshold service, outreach/drug scene Scotland, United Kingdom 2

Displaying results 1–10 of 29 where Substances addressed by the intervention is Opiates

<< previous next >>

Survey

Dear visitor,

We're currently conducting a short survey of this resource (EDDRA: Exchange on Drug Demand Reduction Action). The survey will take no more than 2 minutes and we would be really grateful for your contribution.

No, thanks — maybe some other time

Yes, I'll take the survey!

Many thanks,

The EDDRA team

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 20 January 2012